GLP-1 Agonists Market Evolution: Breakthrough Therapies, Investment...

Ajouter une nouvelle offre d'emploi Health

2026-08-30 08:05:14 -

GLP-1 Agonists Market Evolution: Breakthrough Therapies, Investment Trends, and Outlook to 2036

The glucagon-like peptide-1 agonists market is currently ruled by two names — Eli Lilly and Novo Nordisk — who together hold close to 94% of global share. That kind of concentration makes glp 1 agonist market share tracking almost a two-company exercise today, but the picture is shifting fast. Upcoming patent expiries, biosimilar entrants, and a widening pipeline mean the glp-1...

0 Commentaires 0 Parts 20 Vue 0 Aperçu